Literature DB >> 12646038

Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist.

Claus Riemer1, Edilio Borroni, Bernard Levet-Trafit, James R Martin, Sonia Poli, Richard H P Porter, Michael Bös.   

Abstract

A small series of aryl pyridyl sulfones has been prepared and investigated for its 5-HT(6) receptor binding properties. Thereof, pyrrolidinyl derivative 11 proved to be a very potent (pK(i) 9) and selective 5-HT(6) receptor antagonist. By means of in vivo microdialysis in the frontal cortex and a passive avoidance paradigm, where 11 reversed a scopolamine induced retention deficit, a functional correlation between 5-HT(6) receptors and cholinergic neurotransmission could be shown, supporting the therapeutic potential of 5-HT(6) receptors in the treatment of cognitive deficits.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646038     DOI: 10.1021/jm021085c

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  30 in total

1.  Distribution of serotonin receptor of type 6 (5-HT₆) in human brain post-mortem. A pharmacology, autoradiography and immunohistochemistry study.

Authors:  Donatella Marazziti; Stefano Baroni; Andrea Pirone; Gino Giannaccini; Laura Betti; Lara Schmid; Elena Vatteroni; Lionella Palego; Franco Borsini; Fabio Bordi; Ilaria Piano; Claudia Gargini; Maura Castagna; Mario Catena-Dell'osso; Antonio Lucacchini
Journal:  Neurochem Res       Date:  2012-01-26       Impact factor: 3.996

Review 2.  Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models.

Authors:  L Lyon; L M Saksida; T J Bussey
Journal:  Psychopharmacology (Berl)       Date:  2011-11-10       Impact factor: 4.530

3.  Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats.

Authors:  Katarzyna Fijał; Piotr Popik; Agnieszka Nikiforuk
Journal:  Psychopharmacology (Berl)       Date:  2013-08-18       Impact factor: 4.530

Review 4.  Alzheimer's disease and age-related memory decline (preclinical).

Authors:  Alvin V Terry; Patrick M Callahan; Brandon Hall; Scott J Webster
Journal:  Pharmacol Biochem Behav       Date:  2011-02-24       Impact factor: 3.533

5.  Central nervous system effects of the interaction between risperidone (single dose) and the 5-HT6 antagonist SB742457 (repeated doses) in healthy men.

Authors:  Marieke Liem-Moolenaar; Mandana Rad; Stefano Zamuner; Adam F Cohen; Francesca Lemme; Kari L Franson; Joop M A van Gerven; Emilio Merlo Pich
Journal:  Br J Clin Pharmacol       Date:  2011-06       Impact factor: 4.335

6.  5-HT6 receptor blockade differentially affects scopolamine-induced deficits of working memory, recognition memory and aversive learning in mice.

Authors:  Virginie Da Silva Costa-Aze; Anne Quiedeville; Michel Boulouard; François Dauphin
Journal:  Psychopharmacology (Berl)       Date:  2012-02-25       Impact factor: 4.530

7.  The effects of PRX-07034, a novel 5-HT6 antagonist, on cognitive flexibility and working memory in rats.

Authors:  Eric G Mohler; Phillip M Baker; Kimberly S Gannon; Simon S Jones; Sharon Shacham; John A Sweeney; Michael E Ragozzino
Journal:  Psychopharmacology (Berl)       Date:  2011-10-12       Impact factor: 4.530

8.  Dorsomedial prefrontal cortex 5-HT6 receptors regulate anxiety-like behavior.

Authors:  Fei Geng; Jia Tian; Jian-Lin Wu; Yun Luo; Wen-Jun Zou; Chao Peng; Gui-Feng Lu
Journal:  Cogn Affect Behav Neurosci       Date:  2018-02       Impact factor: 3.282

9.  Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats.

Authors:  Gregory V Carr; Lee E Schechter; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2010-03-09       Impact factor: 4.530

10.  Effects of 5-HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat.

Authors:  B Marcos; T T Chuang; F J Gil-Bea; M J Ramirez
Journal:  Br J Pharmacol       Date:  2008-07-14       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.